U.S., May 24 -- ClinicalTrials.gov registry received information related to the study (NCT06987396) titled 'Clinical Investigation to Assess the Effect of Betaglucan Administration in HPV Patients' on May 15.
Brief Summary: Randomised, controlled clinical study to assess the efficacy and tolerability of an oral supplementation of 1000 mg daily of Betaglucans in the evolution of patients with Human Papilloma Virus (HPV). The improvement is measured by DNA PCR test, cytology and a specific RNA test.
Study Start Date: May 15, 2023
Study Type: INTERVENTIONAL
Condition:
HPV
Intervention:
DIETARY_SUPPLEMENT: 1000 mg Betaglucans (daily)
Patients in the experimental group receive betaglucans supplement in capsule form, administered orally
...